Development of Interactive Software for Bayesian Optimal Phase 1 Clinical Trial Design *

Perevozskaya I. Constrained Bayesian Optimal Designs for Phase I Clinical Trials. Baltimore: University of Maryland: 2001 (doctoral dissertation).

Haines LM Perevozskaya I Rosenberger WF . Bayesian optimal designs for phase I clinical trials. Biometrics. 2003; 59:591–600.

Rosenberger WF Haines LM . Competing designs for phase I clinical trials: a review. Stat Med. 2002; 21:2757–2770.

Atkinson AC Donev AN . Optimum Experimental Designs. Oxford, United Kingdom: Clarendon; 1992.

Clyde M Chaloner K . The equivalence of constrained and weighted designs in multiple objective problems. J Am Stat Assoc. 1996; 91:1236–1244.

Babb J Rogatko A Zacks S . Cancer phase 1 clinical trials: efficient dose escalation with overdose control. Stat Med. 1994; 17:1103–1120.

Whitehead J Brunier H . Bayesian decision procedures for dose determining experiments. Stat Med. 1995; 14:885–893.

Whitehead J Williamson D . Bayesian decision procedures based on logistic regression models for dose-finding studies. Stat Med. 1998; 8: 445–467.

Pukelsheim F. Optimal Design of Experiments. New York: Wiley; 1993.

Flournoy N . A clinical experiment in bone marrow transplantation: estimating a percentage point of a quantal response curve. In Case Studies in Bayesian Statistics. Gatsonis C Hodges JS Kass RE Singpurwalla ND , eds. New York: Springer: 1993.

Tsutakawa RK . Bayesian inference for bioassay. Technical Report 52. Columbia, MO: University of Missouri; 1975.

Whitehead J Zhou Y Patterson S Webber D Francis S . Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers. Biostatistics. 2001; 2:47–61.

McLeish DL Tosh D . Sequential designs in bioassay. Biometrics. 1990; 46:103–116.

Silvapulle M . On the existence of maximum likelihood estimators for the binomial response models. J Roy Stat Soc. B 1981; 43:310–313.